RS20080439A - Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer - Google Patents
Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymerInfo
- Publication number
- RS20080439A RS20080439A RSP-2008/0439A RSP20080439A RS20080439A RS 20080439 A RS20080439 A RS 20080439A RS P20080439 A RSP20080439 A RS P20080439A RS 20080439 A RS20080439 A RS 20080439A
- Authority
- RS
- Serbia
- Prior art keywords
- polymer
- acid
- pharmaceutical composition
- sustained release
- basis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Farmaceutska kompozicija sa zadržanim otpuštanjem koja sadrži bar jedno slabo rastvorljivo aktivno sredstvo(a), bar jedno sredstvo za poboljšanje rastvaranja, polimerni sistem za kontrolu brzine otpuštanja koji se sastoji od u kiselini rastvorlj ivog polimera i pH-nezavisnog polimera, i opciono druge farmaceutski prihvatljive ekscipijente. Sadašnji pronalazak takođe opisuje postupak za dobijanje takvih kompozicija i metod za njihovu upotrebu. Kompozicije sa zadržanim otpuštanjem su korisne za obezbeđivanje terapeutski efikasnih nivoa aktivnog sredstva(-ava) u produženim vremenskim periodima.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN832DE2006 | 2006-03-27 | ||
PCT/IN2007/000110 WO2007110878A1 (en) | 2006-03-27 | 2007-03-19 | Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer. |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20080439A true RS20080439A (en) | 2009-05-06 |
Family
ID=38540835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2008/0439A RS20080439A (en) | 2006-03-27 | 2007-03-19 | Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100234288A1 (sr) |
EP (1) | EP2004150A1 (sr) |
JP (1) | JP2009531420A (sr) |
CN (1) | CN101410096A (sr) |
AU (1) | AU2007230549A1 (sr) |
BR (1) | BRPI0709222A2 (sr) |
CA (1) | CA2647421A1 (sr) |
CR (1) | CR10404A (sr) |
EA (1) | EA200870379A1 (sr) |
MA (1) | MA30359B1 (sr) |
MX (1) | MX2008012486A (sr) |
RS (1) | RS20080439A (sr) |
TN (1) | TNSN08365A1 (sr) |
WO (1) | WO2007110878A1 (sr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5222550B2 (ja) * | 2007-12-27 | 2013-06-26 | 財團法人工業技術研究院 | 徐放性組成物およびその製造方法 |
EP2268283A2 (en) * | 2008-03-12 | 2011-01-05 | Dexcel Ltd. | Oral modified-release formulations containing thiazepines |
EP2108365A1 (en) * | 2008-04-09 | 2009-10-14 | LEK Pharmaceuticals d.d. | Single dosage pharmaceutical formulation comprising eprosartan mesylate |
EP2317980A2 (en) * | 2008-08-11 | 2011-05-11 | Ratiopharm GmbH | Pharmaceutical compositions of rivaroxaban with modified release properties |
CN101361979B (zh) * | 2008-09-19 | 2011-01-19 | 天津博科林药品包装技术有限公司 | 一种固体制剂薄膜包衣剂及其制备方法 |
WO2010082855A1 (en) * | 2009-01-15 | 2010-07-22 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation |
US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
CN102281881A (zh) * | 2010-02-26 | 2011-12-14 | 上海沪美医药科技有限公司 | 一种含有喹硫平的控(缓)释制剂及其制备方法和用途 |
US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
AU2011288256A1 (en) * | 2010-08-10 | 2013-02-07 | Lupin Limited | Oral controlled release pharmaceutical compositions of Blonanserin |
CN103379917B (zh) * | 2010-11-01 | 2016-10-12 | 梅琳塔治疗公司 | 药物组合物 |
CN102058517A (zh) * | 2010-12-31 | 2011-05-18 | 泰州万全医药科技有限公司 | 一种帕潘立酮缓释剂及其制备方法 |
EP2868319A4 (en) * | 2012-06-29 | 2016-02-24 | Maruishi Pharma | ORAL PHARMACEUTICAL PREPARATION OF ARIPIPRAZOLE |
TWI722988B (zh) * | 2015-06-05 | 2021-04-01 | 瑩碩生技醫藥股份有限公司 | 緩釋性醫藥組合物及其製備方法 |
CN105199115B (zh) * | 2015-10-27 | 2021-01-12 | 中国林业科学研究院林产化学工业研究所 | 一种多孔渗水的三维网状结构的可注射水凝胶的制备及其应用 |
WO2017218772A1 (en) * | 2016-06-17 | 2017-12-21 | The Procter & Gamble Company | Delayed-release particles |
CN108203508A (zh) * | 2016-12-16 | 2018-06-26 | 中国石油化工股份有限公司 | 一种改性尼龙6材料及其制备方法 |
BR112019012573A2 (pt) | 2016-12-20 | 2019-11-19 | Lts Lohmann Therapie Systeme Ag | sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno |
WO2018115001A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
KR101813835B1 (ko) * | 2017-02-17 | 2017-12-29 | 이충근 | 피이지 프리 가용화제 및 이의 제조방법 |
CN107028903B (zh) * | 2017-05-03 | 2020-03-10 | 深圳万和制药有限公司 | 布南色林片剂药物组合物及其制备方法 |
ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
JP2021505595A (ja) | 2017-12-05 | 2021-02-18 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 結晶形およびその製造方法 |
MX2020005518A (es) | 2017-12-05 | 2020-11-06 | Sunovion Pharmaceuticals Inc | Mezclas no racemicas y usos de las mismas. |
US11672781B2 (en) | 2018-05-07 | 2023-06-13 | Prana Biosciences Inc | Metaxalone formulations |
CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
CN109984999B (zh) * | 2019-04-28 | 2021-12-24 | 重庆仁泽医药科技有限公司 | 一种药物组合物及其制备方法和用途 |
JP2022535893A (ja) | 2019-06-04 | 2022-08-10 | サノビオン ファーマシューティカルズ インク | 放出調節製剤およびその使用 |
CN111568856B (zh) * | 2020-06-24 | 2021-07-06 | 珠海舒桐医疗科技有限公司 | 一种阴道凝胶制剂及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
DE60233874D1 (de) * | 2001-06-22 | 2009-11-12 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
US20050096365A1 (en) * | 2003-11-03 | 2005-05-05 | David Fikstad | Pharmaceutical compositions with synchronized solubilizer release |
-
2007
- 2007-03-19 JP JP2009502333A patent/JP2009531420A/ja not_active Withdrawn
- 2007-03-19 CN CNA2007800114250A patent/CN101410096A/zh active Pending
- 2007-03-19 US US12/294,482 patent/US20100234288A1/en not_active Abandoned
- 2007-03-19 EA EA200870379A patent/EA200870379A1/ru unknown
- 2007-03-19 BR BRPI0709222-9A patent/BRPI0709222A2/pt not_active Application Discontinuation
- 2007-03-19 MX MX2008012486A patent/MX2008012486A/es unknown
- 2007-03-19 CA CA002647421A patent/CA2647421A1/en not_active Abandoned
- 2007-03-19 RS RSP-2008/0439A patent/RS20080439A/sr unknown
- 2007-03-19 AU AU2007230549A patent/AU2007230549A1/en not_active Abandoned
- 2007-03-19 WO PCT/IN2007/000110 patent/WO2007110878A1/en active Application Filing
- 2007-03-19 EP EP07736570A patent/EP2004150A1/en not_active Withdrawn
-
2008
- 2008-09-19 TN TNP2008000365A patent/TNSN08365A1/en unknown
- 2008-10-27 MA MA31337A patent/MA30359B1/fr unknown
- 2008-10-27 CR CR10404A patent/CR10404A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2647421A1 (en) | 2007-10-04 |
TNSN08365A1 (en) | 2009-12-29 |
MX2008012486A (es) | 2008-10-10 |
MA30359B1 (fr) | 2009-04-01 |
WO2007110878A1 (en) | 2007-10-04 |
BRPI0709222A2 (pt) | 2011-07-12 |
CN101410096A (zh) | 2009-04-15 |
JP2009531420A (ja) | 2009-09-03 |
US20100234288A1 (en) | 2010-09-16 |
AU2007230549A1 (en) | 2007-10-04 |
EP2004150A1 (en) | 2008-12-24 |
CR10404A (es) | 2008-12-08 |
EA200870379A1 (ru) | 2009-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08365A1 (en) | Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer | |
MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
WO2012027065A3 (en) | Combination therapy for treatment of disease | |
MX2009009463A (es) | Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo. | |
WO2007086078A3 (en) | Novel pharmaceutical compositions and process of preparation thereof | |
TNSN08079A1 (en) | Pharmaceutical compositions for the treatment of inner ear disorders | |
SG152240A1 (en) | Pharmaceutical compositions comprising an amphiphilic starch | |
NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
WO2007054976A3 (en) | Lipid based controlled release pharmaceutical composition | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2006002077A3 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
MY149911A (en) | Methods for administering long-lasting hypoglycemic agents | |
WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
MX2008011429A (es) | Composiciones y metodos de uso de ritonavir para tratar hcv. | |
GB2446341A (en) | Method and system for transdermal drug delivery | |
WO2012020301A3 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
WO2008035229A3 (en) | Compositions and methods for ph targeted drug delivery | |
MY144613A (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
WO2008027793A3 (en) | Ophthalmic pharmaceutical compositions and uses thereof | |
WO2007065625A3 (en) | Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations | |
WO2008004100A9 (en) | Therapeutic compounds |